https://www.selleckchem.com/pr....oducts/peficitinb-as
A further 57 117 people in England were initially identified as being at high risk of recurrence or having their life being shortened by cancer but did not fit the TbnC conceptual framework and were excluded, but their results are also reported under 'group B'. A population living with TbnC cancer can be identified using data currently collected on a national scale in England. This large population living with TbnC cancer requires personalised treatment and support. A population living with TbnC cancer can be ide
Like
Comment
Share
